ReviewMembranes2025
Current Trends and Biotechnological Innovations in Biofouling Control of RO Membranes in Desalination Systems.
Review in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundWater scarcity is a pressing global challenge increasingly addressed by advanced desalination that converts seawater into potable water. Reverse osmosis and ultrafiltration dominate because they deliver permeate with very low impurities. Their principal limitation is membrane biofouling, which causes clogging, raises energy, operation, and maintenance costs, and shortens membrane life. Multiple approaches mitigate biofouling-most notably pretreatment trains and engineered surface coatings-but cleaning remains the most decisive remediation pathway. Current practice distinguishes physical, chemical, and biological cleaning. Biological cleaning has gained momentum by exploiting microorganisms that inherently counter biofilms. These strategies include targeted secretion of enzymes and antifouling metabolites, and the application of whole-cell culture supernatants containing the full suite of secreted components. In addition, predatory bacteria can infiltrate established biofilms and eradicate them by lysing prey, thereby accelerating the removal of adherent biomass. Progress across these bio-based approaches signals meaningful advances in fouling control and could substantially improve the efficiency, reliability, and sustainability of desalination facilities. Collectively, they underscore the transformative potential of biological antifouling agents in operational systems. Realizing that potential will require rigorous evaluation of technical performance, long-term stability, compatibility with polyamide membranes, regulatory acceptance, and environmental safety, ultimately alongside scalable production and cost-effective deployment in full-scale plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.